Brief: Sunshine Biopharma - On Sept 9 Got Letter From Nasdaq That Co Regained Compliance With Bid Price Requirement

Sunshine Biopharma

10/09/2024 22:55

Sunshine Biopharma Inc  SBFM.O :
    * SUNSHINE BIOPHARMA -  ON SEPT 9 GOT LETTER FROM NASDAQ
THAT CO
REGAINED COMPLIANCE WITH BID PRICE REQUIREMENT

Source text for Eikon:  ID:n0001683168-24-006281 
Further company coverage:  SBFM.O